Top

Published in:

01-09-2012 | Original Contribution

Combined fish oil and astaxanthin supplementation modulates rat lymphocyte function

Authors: Rosemari Otton, Douglas Popp Marin, Anaysa Paola Bolin, Rita de Cássia Santos Macedo, Thais Regina Campoio, Claudio Fineto Jr., Beatriz Alves Guerra, José Roberto Leite, Marcelo Paes Barros, Rita Mattei

Published in: European Journal of Nutrition | Issue 6/2012

Abstract

Purpose

Higher intakes of n-3 polyunsaturated fatty acids that are abundant in marine fishes have been long described as a “good nutritional intervention” with increasing clinical benefits to cardiovascular health, inflammation, mental, and neurodegenerative diseases. The present study was designed to investigate the effect of daily fish oil (FO—10 mg EPA/kg body weight (BW) and 7 mg DHA/kg BW) intake by oral gavage associated with the antioxidant astaxanthin (ASTA—1 mg/kg BW) on the redox metabolism and the functional properties of lymphocytes from rat lymph nodes.

Methods

This study was conducted by measurements of lymphocyte proliferation capacity, ROS production [superoxide (O ₂ ^•− ) and hydrogen peroxide (H₂O₂)], nitric oxide (NO^•) generation, intracellular calcium release, oxidative damage to lipids and proteins, activities of major antioxidant enzymes, GSH/GSSG content, and cytokines release.

Results

After 45 days of FO + ASTA supplementation, the proliferation capacity of activated T- and B-lymphocytes was significantly diminished followed by lower levels of O ₂ ^•− , H₂O₂ and NO^• production, and increased activities of total/SOD, GR and GPx, and calcium release in cytosol. ASTA was able to prevent oxidative modification in cell structures through the suppression of the oxidative stress condition imposed by FO. l-selectin was increased by FO, and IL-1β was decreased only by ASTA supplementation.

Conclusion

We can propose that association of ASTA with FO could be a good strategy to prevent oxidative stress induced by polyunsaturated fatty acids and also to potentiate immuno-modulatory effects of FO.

Calder PC (2009) Polyunsaturated fatty acids and inflammatory processes: new twists in an old tale. Biochimie. doi:10.1016/j.biochi.2009.01.008

Calder PC, Yaqoob P (2009) Understanding omega-3 polyunsaturated fatty acids. Postgrad Med 121:148–157. doi:10.3810/pgm.2009.11.2083 CrossRef

Fortin PR, Lew RA, Liang MH, Wright EA, Beckett LA, Chalmers TC, Sperling RI (1995) Validation of a meta-analysis: the effects of fish oil in rheumatoid arthritis. J Clin Epidemiol 48:1379–1390CrossRef

De Caterina R, Cybulsky MI, Clinton SK, Gimbrone MA Jr, Libby P (1994) The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb 14:1829–1836CrossRef

Hughes DA, Southon S, Pinder AC (1996) (n-3) Polyunsaturated fatty acids modulate the expression of functionally associated molecules on human monocytes in vitro. J Nutr 126:603–610

De Caterina R, Libby P (1996) Control of endothelial leukocyte adhesion molecules by fatty acids. Lipids 31(Suppl):S57–S63CrossRef

Hughes DA, Pinder AC, Piper Z, Johnson IT, Lund EK (1996) Fish oil supplementation inhibits the expression of major histocompatibility complex class II molecules and adhesion molecules on human monocytes. Am J Clin Nutr 63:267–272

Calder PC (2006) Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids 75:197–202. doi:10.1016/j.plefa.2006.05.012 CrossRef

Collie-Duguid ES, Wahle KW (1996) Inhibitory effect of fish oil n-3 polyunsaturated fatty acids on the expression of endothelial cell adhesion molecules. Biochem Biophys Res Commun 220:969–974. doi:10.1006/bbrc.1996.0516 CrossRef

10.

Sanderson P, Calder PC (1998) Dietary fish oil diminishes lymphocyte adhesion to macrophage and endothelial cell monolayers. Immunology 94:79–87CrossRef

11.

Calder PC, Yaqoob P, Thies F, Wallace FA, Miles EA (2002) Fatty acids and lymphocyte functions. Br J Nutr 87(Suppl 1):S31–S48CrossRef

12.

Deckelbaum RJ, Calder PC (2010) Dietary n-3 and n-6 fatty acids: are there ‘bad’ polyunsaturated fatty acids? Curr Opin Clin Nutr Metab Care 13:123–124. doi:10.1097/MCO.0b013e328336696d

13.

Barros MP, Pinto E, Colepicolo P, Pedersen M (2001) Astaxanthin and peridinin inhibit oxidative damage in Fe(2+)-loaded liposomes: scavenging oxyradicals or changing membrane permeability? Biochem Biophys Res Commun 288:225–232. doi:10.1006/bbrc.2001.5765 CrossRef

14.

Palozza P, Krinsky NI (1992) Astaxanthin and canthaxanthin are potent antioxidants in a membrane model. Arch Biochem Biophys 297:291–295CrossRef

15.

Iwamoto T, Hosoda K, Hirano R, Kurata H, Matsumoto A, Miki W, Kamiyama M, Itakura H, Yamamoto S, Kondo K (2000) Inhibition of low-density lipoprotein oxidation by astaxanthin. J Atheroscler Thromb 7:216–222

16.

17.

Jacobsson LS, Yuan XM, Zieden B, Olsson AG (2004) Effects of alpha-tocopherol and astaxanthin on LDL oxidation and atherosclerosis in WHHL rabbits. Atherosclerosis 173:231–237. doi:10.1016/j.atherosclerosis.2004.01.003

18.

Ohgami K, Shiratori K, Kotake S, Nishida T, Mizuki N, Yazawa K, Ohno S (2003) Effects of astaxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Invest Ophthalmol Vis Sci 44:2694–2701CrossRef

19.

Naito Y, Uchiyama K, Aoi W, Hasegawa G, Nakamura N, Yoshida N, Maoka T, Takahashi J, Yoshikawa T (2004) Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db/db mice. Biofactors 20:49–59CrossRef

20.

Hussein G, Sankawa U, Goto H, Matsumoto K, Watanabe H (2006) Astaxanthin, a carotenoid with potential in human health and nutrition. J Nat Prod 69:443–449. doi:10.1021/np050354+ CrossRef

21.

Conroy DM, Stubbs CD, Belin J, Pryor CL, Smith AD (1986) The effects of dietary (n-3) fatty acid supplementation on lipid dynamics and composition in rat lymphocytes and liver microsomes. Biochim Biophys Acta 861:457–462CrossRef

22.

Otton R, Carvalho CR, Mendonca JR, Curi R (2002) Low proliferation capacity of lymphocytes from alloxan-diabetic rats: involvement of high glucose and tyrosine phosphorylation of Shc and IRS-1. Life Sci 71:2759–2771CrossRef

23.

Pick E, Mizel D (1981) Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J Immunol Methods 46:211–226CrossRef

24.

Ding AH, Nathan CF, Stuehr DJ (1988) Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 141:2407–2412

25.

Otton R, da Silva DO, Campoio TR, Silveira LR, de Souza MO, Hatanaka E, Curi R (2007) Non-esterified fatty acids and human lymphocyte death: a mechanism that involves calcium release and oxidative stress. J Endocrinol 195:133–143. doi:10.1677/JOE-07-0195 CrossRef

26.

Grynkiewicz G, Poenie M, Tsien RY (1985) A new generation of Ca²⁺ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440–3450

27.

Otton R, Graziola F, Hirata MH, Curi R, Williams JF (1998) Dietary fats alter the activity and expression of glucose-6-phosphate dehydrogenase in rat lymphoid cells and tissues. Biochem Mol Biol Int 46:529–536

28.

Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126CrossRef

29.

Mannervik B (1985) Glutathione peroxidase. Methods Enzymol 113:490–495CrossRef

30.

Ewing JF, Janero DR (1995) Microplate superoxide dismutase assay employing a nonenzymatic superoxide generator. Anal Biochem 232:243–248CrossRef

31.

Fraga CG, Leibovitz BE, Tappel AL (1988) Lipid peroxidation measured as thiobarbituric acid-reactive substances in tissue slices: characterization and comparison with homogenates and microsomes. Free Radic Biol Med 4:155–161CrossRef

32.

Biteau B, Labarre J, Toledano MB (2003) ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin. Nature 425:980–984. doi:10.1038/nature02075 CrossRef

33.

Murphy ME, Kehrer JP (1989) Oxidation state of tissue thiol groups and content of protein carbonyl groups in chickens with inherited muscular dystrophy. Biochem J 260:359–364

34.

Rahman I, Kode A, Biswas SK (2006) Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method. Nat Protoc 1:3159–3165. doi:10.1038/nprot.2006.378 CrossRef

35.

Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254CrossRef

36.

Calder PC (2007) Immunological parameters: what do they mean? J Nutr 137:773S–780S

37.

Bolin AP, Macedo RC, Marin DP, Barros MP, Otton R (2010) Astaxanthin prevents in vitro auto-oxidative injury in human lymphocytes. Cell Biol Toxicol 26:457–467. doi:10.1007/s10565-010-9156-4

38.

Pompeia C, Lopes LR, Miyasaka CK, Procopio J, Sannomiya P, Curi R (2000) Effect of fatty acids on leukocyte function. Braz J Med Biol Res 33:1255–1268CrossRef

39.

Wang H, Xie X, Lu WG, Ye DF, Chen HZ, Li X, Cheng Q (2004) Ovarian carcinoma cells inhibit T cell proliferation: suppression of IL-2 receptor beta and gamma expression and their JAK-STAT signaling pathway. Life Sci 74:1739–1749CrossRef

40.

Gorjao R, Cury-Boaventura MF, de Lima TM, Curi R (2007) Regulation of human lymphocyte proliferation by fatty acids. Cell Biochem Funct 25:305–315. doi:10.1002/cbf.1388 CrossRef

41.

Denys A, Hichami A, Khan NA (2005) n-3 PUFAs modulate T-cell activation via protein kinase C-alpha and -epsilon and the NF-kappa B signaling pathway. J Lipid Res 46:752–758. doi:10.1194/jlr.M400444-JLR200 CrossRef

42.

Bhuvaneswari V, Nagini S (2005) Lycopene: a review of its potential as an anticancer agent. Curr Med Chem Anticancer Agents 5:627–635CrossRef

43.

Huang CS, Shih MK, Chuang CH, Hu ML (2005) Lycopene inhibits cell migration and invasion and upregulates Nm23–H1 in a highly invasive hepatocarcinoma, SK-Hep-1 cells. J Nutr 135:2119–2123

44.

Kim YH, Koh HK, Kim DS (2010) Down-regulation of IL-6 production by astaxanthin via ERK-, MSK-, and NF-kappa B-mediated signals in activated microglia. Int Immunopharmacol 10:1560–1572. doi:10.1016/j.intimp.2010.09.007

45.

Odeberg JM, Kaufmann P, Kroon KG, Hoglund P (2003) Lipid drug delivery and rational formulation design for lipophilic drugs with low oral bioavailability, applied to cyclosporine. Eur J Pharm Sci 20:375–382CrossRef

46.

Okada Y, Ishikura M, Maoka T (2009) Bioavailability of astaxanthin in Haematococcus algal extract: the effects of timing of diet and smoking habits. Biosci Biotechnol Biochem 73:1928–1932CrossRef

47.

Petri D, Lundebye AK (2007) Tissue distribution of astaxanthin in rats following exposure to graded levels in the feed. Comp Biochem Physiol C Toxicol Pharmacol 145:202–209. doi:10.1016/j.cbpc.2006.12.008 CrossRef

48.

Razzaq TM, Ozegbe P, Jury EC, Sembi P, Blackwell NM, Kabouridis PS (2004) Regulation of T-cell receptor signalling by membrane microdomains. Immunology 113:413–426. doi:10.1111/j.1365-2567.2004.01998.x CrossRef

49.

Harder T (2004) Lipid raft domains and protein networks in T-cell receptor signal transduction. Curr Opin Immunol 16:353–359. doi:10.1016/j.coi.2004.03.013 CrossRef

50.

Wu M, Harvey KA, Ruzmetov N, Welch ZR, Sech L, Jackson K, Stillwell W, Zaloga GP, Siddiqui RA (2005) Omega-3 polyunsaturated fatty acids attenuate breast cancer growth through activation of a neutral sphingomyelinase-mediated pathway. Int J Cancer 117:340–348. doi:10.1002/ijc.21238 CrossRef

51.

Meydani M, Azzi A (2009) Diabetes risk: antioxidants or lifestyle? Am J Clin Nutr 90:253–254. doi:10.3945/ajcn.2009.28177 CrossRef

52.

Roth S, Droge W (1987) Regulation of T-cell activation and T-cell growth factor (TCGF) production by hydrogen peroxide. Cell Immunol 108:417–424CrossRef

53.

Keyse SM, Tyrrell RM (1990) Induction of the heme oxygenase gene in human skin fibroblasts by hydrogen peroxide and UVA (365 nm) radiation: evidence for the involvement of the hydroxyl radical. Carcinogenesis 11:787–791CrossRef

54.

Schreck R, Rieber P, Baeuerle PA (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10:2247–2258

55.

Luostarinen R, Saldeen T (1996) Dietary fish oil decreases superoxide generation by human neutrophils: relation to cyclooxygenase pathway and lysosomal enzyme release. Prostaglandins Leukot Essent Fatty Acids 55:167–172CrossRef

56.

Fisher M, Levine PH, Weiner BH, Johnson MH, Doyle EM, Ellis PA, Hoogasian JJ (1990) Dietary n-3 fatty acid supplementation reduces superoxide production and chemiluminescence in a monocyte-enriched preparation of leukocytes. Am J Clin Nutr 51:804–808

57.

Tayyebi-Khosroshahi H, Houshyar J, Tabrizi A, Vatankhah AM, Razzagi Zonouz N, Dehghan-Hesari R (2010) Effect of omega-3 fatty acid on oxidative stress in patients on hemodialysis. Iran J Kidney Dis 4(4):322–326

58.

Kim SJ, Zhang Z, Saha A, Sarkar C, Zhao Z, Xu Y, Mukherjee AB (2010) Omega-3 and omega-6 fatty acids suppress ER- and oxidative stress in cultured neurons and neuronal progenitor cells from mice lacking PPT1. Neurosci Lett 479:292–296. doi:10.1016/j.neulet.2010.05.083

59.

Komatsu W, Ishihara K, Murata M, Saito H, Shinohara K (2003) Docosahexaenoic acid suppresses nitric oxide production and inducible nitric oxide synthase expression in interferon-gamma plus lipopolysaccharide-stimulated murine macrophages by inhibiting the oxidative stress. Free Radic Biol Med 34:1006–1016CrossRef

60.

Lu G, Greene EL, Nagai T, Egan BM (1998) Reactive oxygen species are critical in the oleic acid-mediated mitogenic signaling pathway in vascular smooth muscle cells. Hypertension 32:1003–1010CrossRef

61.

Kelley DS, Hubbard NE, Erickson KL (2005) Regulation of human immune and inflammatory responses by dietary fatty acids. Adv Food Nutr Res 50:101–138. doi:10.1016/S1043-4526(05)50004-4 CrossRef

62.

Fritsche K (2006) Fatty acids as modulators of the immune response. Annu Rev Nutr 26:45–73. doi:10.1146/annurev.nutr.25.050304.092610 CrossRef

63.

Lecchi C, Invernizzi G, Agazzi A, Ferroni M, Pisani LF, Savoini G, Ceciliani F (2011) In vitro modulation of caprine monocyte immune functions by omega-3 polyunsaturated fatty acids. Vet J 189(3):353–355. doi:10.1016/j.tvjl.2010.09.001

64.

Guimaraes AR, Curi R (1991) Metabolic changes induced by w-3 polyunsaturated fatty acid rich-diet (w-3 PUFA) on the thymus, spleen and mesenteric lymph nodes of adult rats. Biochem Int 25:689–695

65.

Krinsky NI, Johnson EJ (2005) Carotenoid actions and their relation to health and disease. Mol Aspects Med 26:459–516. doi:10.1016/j.mam.2005.10.001 CrossRef

66.

Nakano M, Onodera A, Saito E, Tanabe M, Yajima K, Takahashi J, Nguyen VC (2008) Effect of astaxanthin in combination with alpha-tocopherol or ascorbic acid against oxidative damage in diabetic ODS rats. J Nutr Sci Vitaminol 54:329–334CrossRef

67.

Ikeuchi M, Koyama T, Takahashi J, Yazawa K (2007) Effects of astaxanthin in obese mice fed a high-fat diet. Biosci Biotechnol Biochem 71:893–899CrossRef

68.

Naguib YM (2000) Antioxidant activities of astaxanthin and related carotenoids. J Agric Food Chem 48:1150–1154CrossRef

69.

Brechard S, Tschirhart EJ (2008) Regulation of superoxide production in neutrophils: role of calcium influx. J Leukoc Biol 84:1223–1237. doi:10.1189/jlb.0807553 CrossRef

70.

Prasad A, Bloom MS, Carpenter DO (2010) Role of calcium and ROS in cell death induced by polyunsaturated fatty acids in murine thymocytes. J Cell Physiol 225:829–836. doi:10.1002/jcp.22290

71.

Yog R, Barhoumi R, McMurray DN, Chapkin RS (2010) n-3 polyunsaturated fatty acids suppress mitochondrial translocation to the immunologic synapse and modulate calcium signaling in T cells. J Immunol 184(10):5865–5873. doi:10.4049/jimmunol.0904102

72.

Lin TY, Lu CW, Wang SJ (2010) Astaxanthin inhibits glutamate release in rat cerebral cortex nerve terminals via suppression of voltage-dependent Ca(2+) entry and mitogen-activated protein kinase signaling pathway. J Agric Food Chem 58:8271–8278. doi:10.1021/jf101689t

73.

Macedo RC, Bolin AP, Marin DP, Otton R (2010) Astaxanthin addition improves human neutrophils function: in vitro study. Eur J Nutr 49:447–457. doi:10.1007/s00394-010-0103-1

74.

Maoka T, Etoh T, Kishimoto S, Sakata S (2011) Carotenoids and their fatty acid esters in the petals of Adonis aestivalis. J Oleo Sci 60:47–52

75.

Wu TH, Liao JH, Hou WC, Huang FY, Maher TJ, Hu CC (2006) Astaxanthin protects against oxidative stress and calcium-induced porcine lens protein degradation. J Agric Food Chem 54:2418–2423. doi:10.1021/jf052651q76 CrossRef

76.

Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M, Sugimoto Y, Miyazaki S, Tsujimoto G (2005) Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 11:90–94. doi:10.1038/nm1168 CrossRef

77.

Picker LJ, Butcher EC (1992) Physiological and molecular mechanisms of lymphocyte homing. Annu Rev Immunol 10:561–591. doi:10.1146/annurev.iy.10.040192.003021 CrossRef

78.

Mora C, Grewal IS, Wong FS, Flavell RA (2004) Role of l-selectin in the development of autoimmune diabetes in non-obese diabetic mice. Int Immunol 16:257–264CrossRef

Title: Combined fish oil and astaxanthin supplementation modulates rat lymphocyte function
Authors: Rosemari Otton
Douglas Popp Marin
Anaysa Paola Bolin
Rita de Cássia Santos Macedo
Thais Regina Campoio
Claudio Fineto Jr.
Beatriz Alves Guerra
José Roberto Leite
Marcelo Paes Barros
Rita Mattei
Publication date: 01-09-2012
Publisher: Springer-Verlag
Published in: European Journal of Nutrition / Issue 6/2012
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI: https://doi.org/10.1007/s00394-011-0250-z

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 6/2012

Oleic acid inhibits store-operated calcium entry in human colorectal adenocarcinoma cells

Applying multilevel model to the relationship of dietary patterns and colorectal cancer: an ongoing case–control study in Córdoba, Argentina

Effect of iodine source and dose on growth and iodine content in tissue and plasma thyroid hormones in fattening pigs

l-Theanine extends lifespan of adult Caenorhabditis elegans

A maternal erythrocyte DHA content of approximately 6 g% is the DHA status at which intrauterine DHA biomagnifications turns into bioattenuation and postnatal infant DHA equilibrium is reached

High-level dietary fibre up-regulates colonic fermentation and relative abundance of saccharolytic bacteria within the human faecal microbiota in vitro

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage